STLN insider transactions
Starling Oncology Inc. (STLN) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.
STLN insiders
Everyone who has filed a Form 3, 4, 5 or 144 at Starling Oncology Inc., latest first. Follow anyone to get their next filing.
- Brad HivelyDirector, since November 2021+$107K-$7.95M
- Jorey Chernett10% owner, since March 2026+$2.69M
- Mohit KaushalDirector-$393K
- Anne McGeorgeDirector, since November 2021
- Mark L PacalaDirector, since September 2022+$94.3K-$200K
- Mark StolperDirector, since January 2026
- Kimberly Jo TzoumakasDirector, since February 2026
- Karen Marie JohnsonDirector, since November 2021+$37.7K
- Yale PodnosChief Medical Officer, since November 2021+$9,434-$277K
- Daniel VirnichChief Executive Officer, since November 2021+$23.6K-$7,639
- Robert Ross CarterChief Financial Officer, since September 2024+$9,434-$879
- Kristin EnglandChief Administrative Officer, since July 2025
- Jeffrey LangsamChief Clinical Officer, since May 2025
- Gabriel LingDirector, since September 2022
- M33 Growth I L.P.Director, since November 2021-$28.4M
- Richard A BaraschDirector+$1.52M
- Jeremy CastleChief Operating Officer, since September 2023+$9,434
- Havencrest Healthcare Partners, L.P.10% owner, since November 2021-$10.5M
- Mihir ShahChief Financial Officer, since April 2022+$127K
- Maeve O'MearaDirector, since November 2021
- Matthew P MillerOfficer, since March 2022+$70K-$1,170
- Ravi Yang SarinDirector, since November 2021
- Diona SimoneitOfficer, since April 2022-$385
- Richy Agajanian10% owner, since November 2021-$9.6M
- Scott DalgleishOfficer, since November 2021
- DFP Sponsor LLC10% owner
- James E Flynn10% owner
Recent Form 3, 4, and 5 filings for STLN
No insider items on the wire yet for STLN. View all STLN news.